You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
先瑞達醫療-B(06669.HK):VERICOR-RS的註冊申請獲中國國家藥品監督管理局批准
格隆匯 03-26 19:32

格隆匯3月26日丨先瑞達醫療-B(06669.HK)發佈公吿,於2024年3月20日,公司收到中國國家藥品監督管理局對微導管Vericor-RS的註冊批准。該產品適用於冠脈及外周血管經皮介入手術中,針對狹窄血管病變部位,引導導絲,併為交換導絲和輸送生理鹽水或診斷造影劑提供通道。Vericor-RS具有優異的扭轉性能,在手術中可以幫助醫生通過旋轉微導管更好地逆向穿通血管病變部位。公司將適時在中國市場開展營銷活動。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account